Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Phaarmasia Limited

Market Cap 513M 5.44M 4.74M 4.39M 4.11M 7.71M 7.76M 52.12M 20.2M 253M 20.42M 19.99M 877M P/E 2024
-38.3x
P/E 2025 -12.6x
Enterprise Value 511M 5.42M 4.73M 4.38M 4.1M 7.68M 7.73M 51.93M 20.12M 252M 20.35M 19.91M 874M EV / Sales 2024
0.64x
EV / Sales 2025 0.81x
Free-Float
-
Yield 2024 *
-
Yield 2025 -
1 day-5.00%
1 week-5.21%
Current month+28.19%
1 month+17.49%
3 months+22.30%
6 months-2.83%
Current year-11.94%
1 week 90.25
Extreme 90.25
105.54
1 month 75.59
Extreme 75.59
111.13
Current year 69
Extreme 69
131.75
1 year 26
Extreme 26
131.75
3 years 22.11
Extreme 22.11
131.75
5 years 20.2
Extreme 20.2
131.75
10 years 10.3
Extreme 10.3
131.75
Manager TitleAgeSince
Director of Finance/CFO - 12/02/2016
Compliance Officer - 03/01/2020
Director TitleAgeSince
Chairman 71 14/10/2010
Director/Board Member 55 09/12/2012
Director/Board Member 63 19/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-5.21%+192.00%+294.75% 7.57M
-1.21%-3.04%+39.94%+145.38% 980B
-2.48%-5.18%+51.52%+39.07% 550B
-2.14%-4.94%+16.71%+56.15% 382B
+0.25%-3.09%+23.00%+15.81% 317B
+0.61%-1.69%+25.42%+13.64% 270B
+0.22%-3.10%+24.25%+30.21% 269B
+4.59%+1.98%-40.02%-45.89% 191B
-1.19%-4.95%+16.56%+47.00% 182B
-1.35%-1.46%+14.59%+56.94% 154B
Average -0.77%-3.19%+36.40%+65.30% 329.4B
Weighted average by Cap. -0.79%-3.67%+27.98%+63.98%

Financials

2024 2025
Net sales 306M 3.24M 2.83M 2.62M 2.45M 4.6M 4.62M 31.06M 12.04M 151M 12.17M 11.91M 523M 244M 2.58M 2.25M 2.09M 1.95M 3.66M 3.68M 24.74M 9.59M 120M 9.69M 9.49M 416M
Net income -5.18M -54.92K -47.88K -44.35K -41.52K -77.86K -78.33K -526K -204K -2.55M -206K -202K -8.86M -15.89M -168K -147K -136K -127K -239K -240K -1.61M -625K -7.82M -632K -619K -27.16M
Net Debt -3.43M -36.37K -31.71K -29.37K -27.5K -51.57K -51.88K -348K -135K -1.69M -137K -134K -5.87M -1.94M -20.53K -17.9K -16.58K -15.52K -29.1K -29.28K -197K -76.22K -953K -77.06K -75.4K -3.31M
Logo Phaarmasia Limited
Phaarmasia Limited is an India-based company, which is primarily engaged in the manufacturing and sale of oral contraceptive pills (OCPs). The Company manufactures and markets oral contraceptive tablets with various therapeutic dosage combinations along with iron tablets for the Ministry of Health & Family Welfare and for exports. Its product categories include Hormone Products and Herbal Products. Its hormone products include Estradiol Valerate Tablets; Medroxyprogesterone Acetate Tablets; Cabergoline Tablets; Clomiphene Citrate Tablets; Levonorgestrel Tablet; Fluoxymesterone tablets; Liothyronine Sodium tablets; Oxandrolone tablets and others. Its herbal products include Smyle Herbal Toothpaste; Smyle Cough & Sore Throat Reliver and Smyle Mouth Ulcer Gel. Its injectables include Testosterone Cypionate Injection; Methenolone Enanthate Injection; Drostanolone, Testosterone and Trenbolone Inj, and Stanozolol Cypionate Inj.
Employees
36
Date Price Change Volume
19/06/26 99.28 -5.00% 594
18/06/26 104.50 +4.76% 623
17/06/26 99.75 +5.00% 279
16/06/26 95.00 -5.00% 2,497
15/06/26 100.00 -4.53% 1,212
  1. Stock Market
  2. Stocks
  3. PHRMASI6 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!